Wright; Curtis
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wright; Curtis.The latest application filed is for "splice sleeve holder nest".
Company Profile
14.89.134
- Wright; Curtis - Rockport MA
- Wright; Curtis - Fairview NC
- Wright; Curtis - Royal Oak MI
- Wright; Curtis - Norwalk CT
- Wright; Curtis - Gloucester MA
- Wright; Curtis - Lake Hopatcong NJ
- Wright; Curtis - Nowalk CT
Patent Activity
| Patent | Date |
|---|---|
| Pharmaceutical formulation containing gelling agent Grant 11,135,171 - Wright , et al. October 5, 2 | 2021-10-05 |
| Splice Sleeve Holder Nest App 20210231898 - Seo; Sumio ; et al. | 2021-07-29 |
| Instrument panel with reinforcement member Grant 11,001,309 - Vitale , et al. May 11, 2 | 2021-05-11 |
| Instrument Panel With Reinforcement Member App 20200317275 - Vitale; Peter ; et al. | 2020-10-08 |
| Oxycodone formulations Grant 10,660,886 - Oshlack , et al. | 2020-05-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20200138720 - Wright; Curtis ; et al. | 2020-05-07 |
| Tamper resistant oral opioid agonist formulations Grant 10,588,865 - Oshlack , et al. | 2020-03-17 |
| Pharmaceutical formulation containing gelling agent Grant 10,537,526 - Wright , et al. Ja | 2020-01-21 |
| Pharmaceutical formulation containing gelling agent Grant 10,500,160 - Wright , et al. Dec | 2019-12-10 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20190350868 - Oshlack; Benjamin ; et al. | 2019-11-21 |
| Tamper resistant oral opioid agonist formulations Grant 10,350,173 - Oshlack , et al. July 16, 2 | 2019-07-16 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190117580 - Wright; Curtis ; et al. | 2019-04-25 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190110996 - Wright; Curtis ; et al. | 2019-04-18 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190070119 - Wright; Curtis ; et al. | 2019-03-07 |
| Pharmaceutical formulation containing gelling agent Grant 10,206,881 - Wright , et al. Feb | 2019-02-19 |
| Pharmaceutical Formulation Containing Gelling Agent App 20190015341 - Wright; Curtis ; et al. | 2019-01-17 |
| Pharmaceutical formulation containing gelling agent Grant 10,130,586 - Wright , et al. November 20, 2 | 2018-11-20 |
| Pharmaceutical formulation containing gelling agent Grant 10,076,497 - Wright , et al. September 18, 2 | 2018-09-18 |
| Pharmaceutical formulation containing gelling agent Grant 10,071,057 - Wright , et al. September 11, 2 | 2018-09-11 |
| Pharmaceutical formulation containing gelling agent Grant 10,064,825 - Wright , et al. September 4, 2 | 2018-09-04 |
| Pharmaceutical formulation containing gelling agent Grant 10,064,824 - Wright , et al. September 4, 2 | 2018-09-04 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180147151 - Wright; Curtis ; et al. | 2018-05-31 |
| Pharmaceutical formulation containing gelling agent Grant 9,968,559 - Wright , et al. May 15, 2 | 2018-05-15 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180125788 - Wright; Curtis ; et al. | 2018-05-10 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 9,949,930 - Breder , et al. April 24, 2 | 2018-04-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180055771 - Wright; Curtis ; et al. | 2018-03-01 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20180042859 - Oshlack; Benjamin ; et al. | 2018-02-15 |
| Pharmaceutical formulation containing gelling agent Grant 9,877,924 - Wright , et al. January 30, 2 | 2018-01-30 |
| Pharmaceutical Formulation Containing Gelling Agent App 20180021262 - Wright; Curtis ; et al. | 2018-01-25 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20180021330 - Oshlack; Benjamin ; et al. | 2018-01-25 |
| Pharmaceutical formulation containing gelling agent Grant 9,872,836 - Wright , et al. January 23, 2 | 2018-01-23 |
| Pharmaceutical formulation containing gelling agent Grant 9,867,783 - Wright , et al. January 16, 2 | 2018-01-16 |
| Pharmaceutical formulation containing gelling agent Grant 9,867,784 - Wright , et al. January 16, 2 | 2018-01-16 |
| Pharmaceutical formulation containing gelling agent Grant 9,861,583 - Wright , et al. January 9, 2 | 2018-01-09 |
| Pharmaceutical formulation containing gelling agent Grant 9,861,582 - Wright , et al. January 9, 2 | 2018-01-09 |
| Oxycodone Formulations App 20170340626 - OSHLACK; Benjamin ; et al. | 2017-11-30 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,808,453 - Oshlack , et al. November 7, 2 | 2017-11-07 |
| Tamper resistant oral opioid agonist formulations Grant 9,801,828 - Oshlack , et al. October 31, 2 | 2017-10-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170296533 - Wright; Curtis ; et al. | 2017-10-19 |
| Pharmaceutical formulation containing gelling agent Grant 9,757,341 - Wright , et al. September 12, 2 | 2017-09-12 |
| Oxycodone formulations Grant 9,750,736 - Oshlack , et al. September 5, 2 | 2017-09-05 |
| Pharmaceutical formulation containing gelling agent Grant 9,693,961 - Wright , et al. July 4, 2 | 2017-07-04 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20170157115 - Oshlack; Benjamin ; et al. | 2017-06-08 |
| Once-A day oxycodone formulations Grant 9,655,894 - Oshlack , et al. May 23, 2 | 2017-05-23 |
| Once-a-day oxycodone formulations Grant 9,655,893 - Oshlack , et al. May 23, 2 | 2017-05-23 |
| Tamper Resistant Oral Opioid Agonist Formulations App 20170119685 - Oshlack; Benjamin ; et al. | 2017-05-04 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170112765 - Wright; Curtis ; et al. | 2017-04-27 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170065524 - Wright; Curtis ; et al. | 2017-03-09 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170065525 - Wright; Curtis ; et al. | 2017-03-09 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,561,225 - Oshlack , et al. February 7, 2 | 2017-02-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170020863 - Wright; Curtis ; et al. | 2017-01-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20170020864 - Wright; Curtis ; et al. | 2017-01-26 |
| Pharmaceutical formulation containing gelling agent Grant 9,517,207 - Wright , et al. December 13, 2 | 2016-12-13 |
| Tamper-resistant oral opioid agonist formulations Grant 9,456,989 - Oshlack , et al. October 4, 2 | 2016-10-04 |
| Pharmaceutical formulation containing gelling agent Grant 9,387,174 - Wright , et al. July 12, 2 | 2016-07-12 |
| Pharmaceutical formulation containing gelling agent Grant 9,387,173 - Wright , et al. July 12, 2 | 2016-07-12 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151290 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151291 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151357 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151358 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151360 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151297 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151356 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151499 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151355 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151289 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151277 - Wright; Curtis ; et al. | 2016-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160151502 - Wright; Curtis ; et al. | 2016-06-02 |
| Opioid dosage forms having dose proportional steady state C.sub.ave and AUC and less than dose proportional single dose C.sub.max Grant 9,326,959 - Wright , et al. May 3, 2 | 2016-05-03 |
| Pharmaceutical formulation containing gelling agent Grant 9,308,171 - Wright , et al. April 12, 2 | 2016-04-12 |
| Pharmaceutical formulation containing gelling agent Grant 9,308,170 - Wright , et al. April 12, 2 | 2016-04-12 |
| Tamper-resistant oral opioid agonist formulations Grant 9,278,073 - Oshlack , et al. March 8, 2 | 2016-03-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160058716 - Wright; Curtis ; et al. | 2016-03-03 |
| Once-a-day Oxycodone Formulations App 20160030419 - OSHLACK; Benjamin ; et al. | 2016-02-04 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20160008350 - Oshlack; Benjamin ; et al. | 2016-01-14 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000712 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000776 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000718 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000723 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000719 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20160000717 - Wright; Curtis ; et al. | 2016-01-07 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150374628 - Wright; Curtis ; et al. | 2015-12-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150374631 - Wright; Curtis ; et al. | 2015-12-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283128 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283130 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283250 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150283129 - Wright; Curtis ; et al. | 2015-10-08 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150273064 - Wright; Curtis ; et al. | 2015-10-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150273065 - Wright; Curtis ; et al. | 2015-10-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265604 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265602 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265606 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265605 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265607 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150265603 - Wright; Curtis ; et al. | 2015-09-24 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150238481 - Wright; Curtis ; et al. | 2015-08-27 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20150231086 - Oshlack; Benjamin ; et al. | 2015-08-20 |
| Once-a-day Oxycodone Formulations App 20150231131 - OSHLACK; Benjamin ; et al. | 2015-08-20 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 9,101,668 - Oshlack , et al. August 11, 2 | 2015-08-11 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20150182467 - Oshlack; Benjamin ; et al. | 2015-07-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150182628 - Wright; Curtis ; et al. | 2015-07-02 |
| Pharmaceutical formulation containing gelling agent Grant 9,060,976 - Wright , et al. June 23, 2 | 2015-06-23 |
| Pharmaceutical formulation containing gelling agent Grant 9,044,435 - Wright , et al. June 2, 2 | 2015-06-02 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150147391 - Wright; Curtis ; et al. | 2015-05-28 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150148319 - Wright; Curtis ; et al. | 2015-05-28 |
| Pharmaceutical formulation containing gelling agent Grant 9,040,084 - Wright , et al. May 26, 2 | 2015-05-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150140083 - Wright; Curtis ; et al. | 2015-05-21 |
| Once-a-day Oxycodone Formulations App 20150140095 - OSHLACK; Benjamin ; et al. | 2015-05-21 |
| Opioid dosage forms having dose proportional steady state C.sub.ave and AUC and less than dose proportional single dose C.sub.max Grant 9,034,377 - Wright , et al. May 19, 2 | 2015-05-19 |
| Pharmaceutical formulation containing gelling agent Grant 9,034,376 - Wright , et al. May 19, 2 | 2015-05-19 |
| Opioid Agonist Formulations With Releasable And Sequestered Antagonist App 20150110879 - Breder; Christopher ; et al. | 2015-04-23 |
| Formulations Of Low Dose Diclofenac And Beta-cyclodextrin App 20150105467 - Wright; Curtis ; et al. | 2015-04-16 |
| Pharmaceutical formulation containing gelling agent Grant 8,999,961 - Wright , et al. April 7, 2 | 2015-04-07 |
| Pharmaceutical Combinations Of Hydrocodone And Naltrexone App 20150080423 - OSHLACK; Benjamin ; et al. | 2015-03-19 |
| Formulations of low dose diclofenac and beta-cyclodextrin Grant 8,946,292 - Wright , et al. February 3, 2 | 2015-02-03 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent App 20150031718 - Wright; Curtis ; et al. | 2015-01-29 |
| Tamper-resistant oral opioid agonist formulations Grant 8,936,812 - Oshlack , et al. January 20, 2 | 2015-01-20 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150005333 - Wright; Curtis ; et al. | 2015-01-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20150005331 - Wright; Curtis ; et al. | 2015-01-01 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140371257 - Wright; Curtis ; et al. | 2014-12-18 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140357657 - Wright; Curtis ; et al. | 2014-12-04 |
| Pharmaceutical formulation containing gelling agent Grant 8,871,265 - Wright , et al. October 28, 2 | 2014-10-28 |
| Sequestered Antagonist Formulations App 20140296276 - Breder; Christopher ; et al. | 2014-10-02 |
| Opiod agonist formulations with releasable and sequestered antagonist Grant 8,815,287 - Breder , et al. August 26, 2 | 2014-08-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140228390 - Wright; Curtis ; et al. | 2014-08-14 |
| Pharmaceutical Formulation Containing Gelling Agent App 20140213606 - Wright; Curtis ; et al. | 2014-07-31 |
| Abuse Resistant Opioid Containing Transdermal Systems App 20140199383 - Tavares; Lino ; et al. | 2014-07-17 |
| Opioid Dosage Forms Having Dose Proportional Steady State Cave And Auc And Less Than Dose Proportional Single Dose Cmax App 20140187572 - Wright; Curtis ; et al. | 2014-07-03 |
| Sequestered antagonist formulations Grant 8,758,825 - Breder , et al. June 24, 2 | 2014-06-24 |
| Titration dosing regimen for controlled release tramadol Grant 8,722,087 - Wright , et al. May 13, 2 | 2014-05-13 |
| Formulations Of Low Dose Diclofenac And Beta-cyclodextrin App 20140107209 - Wright; Curtis ; et al. | 2014-04-17 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20140099369 - Oshlack; Benjamin ; et al. | 2014-04-10 |
| Sequestered Antagonist Formulations App 20140099376 - Breder; Christopher ; et al. | 2014-04-10 |
| Pharmaceutical formulation containing gelling agent Grant 8,609,683 - Wright , et al. December 17, 2 | 2013-12-17 |
| Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20130317051 - Oshlack; Benjamin ; et al. | 2013-11-28 |
| Opiod Agonist Formulations with Releasable And Sequestered Antagonist App 20130309303 - Breder; Christopher ; et al. | 2013-11-21 |
| Tamper-resistant oral opioid agonist formulations Grant 8,586,088 - Oshlack , et al. November 19, 2 | 2013-11-19 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130303494 - Wright; Curtis ; et al. | 2013-11-14 |
| Formulations of low dose diclofenac and beta-cyclodextrin Grant 8,580,954 - Wright , et al. November 12, 2 | 2013-11-12 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261143 - Wright; Curtis ; et al. | 2013-10-03 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261145 - Wright; Curtis ; et al. | 2013-10-03 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130261144 - Wright; Curtis ; et al. | 2013-10-03 |
| Sequestered Antagonist Formulations App 20130251812 - Breder; Christopher ; et al. | 2013-09-26 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20130251789 - OSHLACK; Benjamin ; et al. | 2013-09-26 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130245055 - Wright; Curtis ; et al. | 2013-09-19 |
| Pharmaceutical formulation containing gelling agent Grant 8,529,948 - Wright , et al. September 10, 2 | 2013-09-10 |
| Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent Grant 8,524,275 - Oshlack , et al. September 3, 2 | 2013-09-03 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 8,518,443 - Breder , et al. August 27, 2 | 2013-08-27 |
| Pharmaceutical Formulation Containing Gelling Agent App 20130217716 - Wright; Curtis ; et al. | 2013-08-22 |
| Sequestered antagonist formulations Grant 8,465,774 - Breder , et al. June 18, 2 | 2013-06-18 |
| Pharmaceutical composition containing gelling agent Grant 8,389,007 - Wright , et al. March 5, 2 | 2013-03-05 |
| Tamper-resistant oral opioid agonist formulations Grant 8,357,399 - Oshlack , et al. January 22, 2 | 2013-01-22 |
| Pharmaceutical formulation containing gelling agent Grant 8,337,888 - Wright , et al. December 25, 2 | 2012-12-25 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20120288565 - Oshlack; Benjamin ; et al. | 2012-11-15 |
| Opioid Agonist Formulations with Releasable And Sequestered Antagonist App 20120288567 - Breder; Christopher ; et al. | 2012-11-15 |
| Nutraceutical product containing anatabine and yerba mate Grant 8,241,680 - Williams , et al. August 14, 2 | 2012-08-14 |
| Tamper-resistant oral opioid agonist formulations Grant 8,236,351 - Oshlack , et al. August 7, 2 | 2012-08-07 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 8,231,901 - Breder , et al. July 31, 2 | 2012-07-31 |
| Pharmaceutical Formulation Containing Gelling Agent App 20120108622 - Wright; Curtis ; et al. | 2012-05-03 |
| Nutraceutical Product Containing Anatabine And Yerba Mate App 20120003341 - Williams; Jonnie R. ; et al. | 2012-01-05 |
| Opioid Agonist Formulations With Releasable And Sequestered Antagonist App 20110256226 - Breder; Christopher ; et al. | 2011-10-20 |
| Pharmaceutical Formulations Containing Opioid Agonist, Opioid Antagonist And Gelling Agent App 20110230510 - Oshlack; Benjamin ; et al. | 2011-09-22 |
| Formulations Of Low Dose Diclofenac And Beta-cyclodextrin App 20110218247 - Wright; Curtis ; et al. | 2011-09-08 |
| Pharmaceutical combinations of oxycodone and naloxone Grant 7,943,173 - Breder , et al. May 17, 2 | 2011-05-17 |
| Once-a-day Oxycodone Formulations App 20110104214 - Oshlack; Benjamin ; et al. | 2011-05-05 |
| Tamper-resistant Oral Opioid Agonist Formulations App 20110097404 - Oshlack; Benjamin ; et al. | 2011-04-28 |
| Opioid agonist formulations with releasable and sequestered antagonist Grant 7,914,818 - Breder , et al. March 29, 2 | 2011-03-29 |
| Once-a-day oxycodone formulations Grant 7,846,476 - Oshlack , et al. December 7, 2 | 2010-12-07 |
| Tamper-resistant oral opioid agonist formulations Grant 7,842,309 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent Grant 7,842,307 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Tamper-resistant oral opioid agonist formulations Grant 7,842,311 - Oshlack , et al. November 30, 2 | 2010-11-30 |
| Sustained-release gel coated compositions Grant 7,790,215 - Sackler , et al. September 7, 2 | 2010-09-07 |
| Pharmaceutical formulation containing gelling agent App 20100168148 - Wright; Curtis ; et al. | 2010-07-01 |
| Tamper-resistant oral opioid agonist formulations Grant 7,718,192 - Oshlack , et al. May 18, 2 | 2010-05-18 |
| Tamper-resistant oral opioid agonist formulations Grant 7,682,632 - Oshlack , et al. March 23, 2 | 2010-03-23 |
| Tamper-resistant oral opioid agonist formulations Grant 7,658,939 - Oshlack , et al. February 9, 2 | 2010-02-09 |
| Pharmaceutical Composition Containing Gelling Agent App 20090081287 - Wright; Curtis ; et al. | 2009-03-26 |
| Titration Dosing Regimen For Controlled Release Tramadol App 20080319085 - Wright; Curtis ; et al. | 2008-12-25 |
| Titration dosing regimen for controlled release tramadol Grant 7,413,749 - Wright , et al. August 19, 2 | 2008-08-19 |
| Opioid Dosage Forms Having Dose Proportional Steady State Cave and Auc and Less Than Dose Proportional Single Dose Cmax App 20080132532 - Wright; Curtis ; et al. | 2008-06-05 |
| Dispensing device App 20080054008 - Wright; Curtis | 2008-03-06 |
| Dispensing device App 20080017658 - Wright; Curtis | 2008-01-24 |
| Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin App 20070232566 - Wright; Curtis ; et al. | 2007-10-04 |
| Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin App 20070232567 - Wright; Curtis ; et al. | 2007-10-04 |
| Artillery fire control system Grant 7,275,691 - Wright , et al. October 2, 2 | 2007-10-02 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent Grant 7,144,587 - Oshlack , et al. December 5, 2 | 2006-12-05 |
| Pharmaceutical formulation containing bittering agent Grant 7,141,250 - Oshlack , et al. November 28, 2 | 2006-11-28 |
| Pharmaceutical combinations of hydrocodone and naltrexone App 20060194826 - Oshlack; Benjamin ; et al. | 2006-08-31 |
| Sequestered antagonist formulations App 20060182801 - Breder; Christopher ; et al. | 2006-08-17 |
| Tamper-resistant oral opioid agonist formulations App 20060039970 - Oshlack; Benjamin ; et al. | 2006-02-23 |
| Tamper-resistant oral opioid agonist formulations App 20050181046 - Oshlack, Benjamin ; et al. | 2005-08-18 |
| Tamper-resistant oral opioid agonist formulations App 20050095291 - Oshlack, Benjamin ; et al. | 2005-05-05 |
| Titration dosing regimen for controlled release tramadol App 20040259956 - Wright, Curtis ; et al. | 2004-12-23 |
| Abuse resistant opioid containing transdermal systems App 20040241218 - Tavares, Lino ; et al. | 2004-12-02 |
| Tamper-resistant oral opioid agonist formulations App 20040186121 - Oshlack, Benjamin ; et al. | 2004-09-23 |
| Controlled-release compositions containing opioid agonist and antagonist App 20040176402 - Oshlack, Benjamin ; et al. | 2004-09-09 |
| Once-a-day oxycodone formulations App 20040170680 - Oshlack, Benjamin ; et al. | 2004-09-02 |
| Tamper resistant oral dosage form App 20040156844 - Wright, Curtis | 2004-08-12 |
| Tamper-resistant oral opioid agonist formulations App 20040092542 - Oshlack, Benjamin ; et al. | 2004-05-13 |
| Controlled-release compositions containing opioid agonist and antagonist Grant 6,716,449 - Oshlack , et al. April 6, 2 | 2004-04-06 |
| Tamper-resistant oral opioid agonist formulations Grant 6,696,088 - Oshlack , et al. February 24, 2 | 2004-02-24 |
| Titratable dosage transdermal delivery system Grant 6,682,757 - Wright January 27, 2 | 2004-01-27 |
| Sustained-release gel coated compositions App 20030190362 - Sackler, Richard S. ; et al. | 2003-10-09 |
| Sequestered antagonist formulations App 20030157168 - Breder, Christopher ; et al. | 2003-08-21 |
| Tamper-resistant oral opioid agonist formulations App 20030143269 - Oshlack, Benjamin ; et al. | 2003-07-31 |
| Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent App 20030124185 - Oshlack, Benjamin ; et al. | 2003-07-03 |
| Opioid agonist formulations with releasable and sequestered antagonist App 20030073714 - Breder, Christopher ; et al. | 2003-04-17 |
| Pharmaceutical formulation containing gelling agent App 20030068375 - Wright, Curtis ; et al. | 2003-04-10 |
| Pharmaceutical combinations of oxycodone and naloxone App 20030069263 - Breder, Christopher D. ; et al. | 2003-04-10 |
| Pharmaceutical formulation containing opioid agonist,opioid antagonist and gelling agent App 20030068371 - Oshlack, Benjamin ; et al. | 2003-04-10 |
| Pharmaceutical formulation containing bittering agent App 20030064099 - Oshlack, Benjamin ; et al. | 2003-04-03 |
| Controlled-release compositions containing opioid agonist and antagonist App 20020010127 - Oshlack, Benjamin ; et al. | 2002-01-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 